계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Janux Therapeutics
company
About
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $125M
- Industries
- Biotechnology,Health Diagnostics,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient’s healthy tissue. Janux technology targets all three stages of the anti-tumor immune response.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$125M
Janux Therapeutics has raised a total of
$125M
in funding over 2 rounds. Their latest funding was raised on
Apr 20, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 20, 2021 | Series B | $125M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Janux Therapeutics is funded by 1 investors.
Hartford HealthCare Endowment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
